Data from Catholic University of Korea Provide New Insights into Cervical Cancer (Pembrolizumab Monotherapy In Heavily Treated Recurrent Cervical Cancer Patients: Case Series Report)

Press/Media

Period3 Aug 2023

Media coverage

1

Media coverage